Clinical Trial Update: Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV [Phase 2]

View source ↗

Summary

Phase 2 study assessing a fixed-dose combination of sofosbuvir (GS-7977) and ledipasvir (GS-5885) for hepatitis C in people with HIV; the trial has completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C, HIV | Phase 2 | Status: COMPLETED | Results posted: 2016-09-15